Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Cardiovascular Research · 31.03.2023 · 119 (2) · 336-356
DOI: 10.1093/cvr/cvac115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 25.07.2022. Verfasst von Mariann Gyöngyösi und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: COVID-19, Heart Diseases. Die Arbeit wurde bisher 151-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, British Heart Foundation, NHLBI NIH HHS.
Abstract (Originalsprache)
Long COVID has become a world-wide, non-communicable epidemic, caused by long-lasting multiorgan symptoms that endure for weeks or months after SARS-CoV-2 infection has already subsided. This scientific document aims to provide insight into the possible causes and therapeutic options available for the cardiovascular manifestations of long COVID. In addition to chronic fatigue, which is a common symptom of long COVID, patients may present with chest pain, ECG abnormalities, postural orthostatic tachycardia, or newly developed supraventricular or ventricular arrhythmias. Imaging of the heart and vessels has provided evidence of chronic, post-infectious perimyocarditis with consequent left or right ventricular failure, arterial wall inflammation, or microthrombosis in certain patient populations. Better understanding of the underlying cellular and molecular mechanisms of long COVID will aid in the development of effective treatment strategies for its cardiovascular manifestations. A number of mechanisms have been proposed, including those involving direct effects on the myocardium, microthrombotic damage to vessels or endothelium, or persistent inflammation. Unfortunately, existing circulating biomarkers, coagulation, and inflammatory markers, are not highly predictive for either the presence or outcome of long COVID when measured 3 months after SARS-CoV-2 infection. Further studies are needed to understand underlying mechanisms, identify specific biomarkers, and guide future preventive strategies or treatments to address long COVID and its cardiovascular sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, 2nd Department of Internal Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
- Department of Immunology, Tufts University School of Medicine, Boston, MA, USA.
- Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Health Data Research UK and Institute of Health Informatics, University College London, London, UK.
- Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands.
- Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
ORCID-Profile: Paula da Costa Martins, Marianna Fontana, Henrique Girao, Massimiliano Gnecchi, Petra Kleinbongard, Thomas Krieg, Cinzia Perrino, Maurizio Pesce, Joost P G Sluijter, Sabine Steffens, Sophie Van Linthout
Förderung
- European Research Council
- British Heart Foundation
- NHLBI NIH HHS
- UCL Hospitals NIHR Biomedical Research Center
- National Institutes of Health
- Austrian Scientific Fund
- Università e Ricerca Scientifica
- Swiss Heart Foundation and Swiss National Science Foundation
Zitieren
APA
Gyöngyösi, M., Alcaide, P., Asselbergs, F. W., Brundel, B. J. J. M., Camici, G. G., Martins, P. D. C., Ferdinandy, P., Fontana, M., Girao, H., Gnecchi, M., Gollmann-Tepeköylü, C., Kleinbongard, P., Krieg, T., Madonna, R., Paillard, M., Pantazis, A., Perrino, C., Pesce, M., Schiattarella, G. G., …, & Davidson, S. M. (2023). Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovascular Research, 119(2), 336-356. https://doi.org/10.1093/cvr/cvac115
Vancouver
Gyöngyösi M, Alcaide P, Asselbergs FW, Brundel BJJM, Camici GG, Martins PDC, et al. Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovascular Research. 2023;119(2):336-356. doi:10.1093/cvr/cvac115
BibTeX
@article{Gyngysi2023,
author = {Gyöngyösi, Mariann and Alcaide, Pilar and Asselbergs, Folkert W and Brundel, Bianca J J M and Camici, Giovanni G and Martins, Paula da Costa and Ferdinandy, Péter and Fontana, Marianna and Girao, Henrique and Gnecchi, Massimiliano and Gollmann-Tepeköylü, Can and Kleinbongard, Petra and Krieg, Thomas and Madonna, Rosalinda and Paillard, Melanie and Pantazis, Antonis and Perrino, Cinzia and Pesce, Maurizio and Schiattarella, Gabriele G and Sluijter, Joost P G and Steffens, Sabine and Tschöpe, Carsten and Van Linthout, Sophie and Davidson, Sean M},
title = {Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {2},
pages = {336--356},
doi = {10.1093/cvr/cvac115}
}
EUVIMED